|
[1]MAILLETTE de BUY WENNIGER L, RAUWS EA, BEUERS U.What an endoscopist should know about immunoglobulin-G4-associated disease of the pancreas and biliary tree[J].Endoscopy, 2012, 44 (1) :66-73.
|
|
[2]DU S, LIU G, CHENG X, et al.Differential diagnosis of immunoglobulin g4-associated cholangitis from cholangiocarcinoma[J].JClin Gastroenterol, 2016, 50 (6) :501-505.
|
|
[3]NOVOTNY I, DITE P, TRNA J, et al.Immunoglobulin G4-related cholangitis:a variant of IgG4-related systemic disease[J].Dig Dis, 2012, 30 (2) :216-219.
|
|
[4]CARRUTHERS MN, STONE JH, KHOSROSHAHI A.The latest on IgG4-RD:a rapidly emerging disease[J].Curr OpinRheumatol, 2012, 24 (1) :60-69.
|
|
[5]ZEN Y, NAKANUMA Y, PORTMANN B.Immunoglobulin G4-related sclerosing cholangitis:pathologic features and histologic mimics[J].Semin Diagn Pathol, 2012, 29 (4) :205-211.
|
|
[6]OSEINI AM, CHAITEERAKIJ R, SHIRE AM, et al.Utility of serum immunoglobulin G4 in distinguishing immunoglobulin G4-associated cholangitis from cholangiocarcinoma[J].Hepatology, 2011, 54 (3) :940-948.
|
|
[7]ZEN Y, NAKANUMA Y.IgG4 Cholangiopathy[J].Int J Hepatol, 2012, 2012:472376.
|
|
[8]HUANG YQ.Recent advances in research of immunoglobulin G4-related sclerosingcholangitis[J].World Chin J Dig, 2012, 20 (27) :2554-2561. (in Chinese) 黄颖秋.IgG4相关硬化性胆管炎的研究进展[J].世界华人消化杂志, 2012, 20 (27) :2554-2561.
|
|
[9]KAWABATA Y, HAYASHI H, YANO S, et al.Liver parenchyma transection-first approach in hemihepatectomy with en bloc caudate lobectomy for hilarcholangiocarcinoma:asafe technique to secure favorable surgical outcomes[J].J Surg Oncol, 2017, 115 (8) :963-970.
|
|
[10]ROSSI GM, ROCCO R, ACCORSI BE, et al.Idiopathic retroperitoneal fibrosis and its overlap with IgG4-related disease[J].Intern Emerg Med, 2017, 12 (3) :287-299.
|
|
[11]ROMPA GT, JABLONSKA AK, GUZEK MT, et al.Sclerosing cholangitis associated with retroperitoneal fibrosis:a case of multisystem fibroinflammatory disorder[J].Hepatol Int, 2010, 4 (4) :779-783.
|
|
[12]CLENDENON JN, ARANDA-MICHEL J, KRISHNA M, et al.Recurrent liver failure caused by IgG4 associated cholangitis[J].Ann Hepatol, 2011, 10 (4) :562-564.
|
|
[13]SHU HJ, TAN B, XUE HD, et al.IgG4-related sclerosing cholangitis with autoimmune pancreatitis and periaortitis:case report and review of the literature[J].J Dig Dis, 2012, 13 (5) :280-286.
|
|
[14]SOHN JW, CHO CM, JUNG MK, et al.A case of autoimmune pancreatitis manifested by a pseudocyst and IgG4-associated cholangitis[J].Gut Liver, 2012, 6 (1) :132-135.
|
|
[15]OKAZAKI K, UCHIDA K, KOYABU M, et al.IgG4 cholangiopathy:current concept, diagnosis, and pathogenesis[J].J Hepatol, 2014, 61 (3) :690-695.
|
|
[16]RASTOGI A, BIHARI C, GROVER S, et al.Hepatobiliary IgG4cholangiopathy:case series and literature review[J].Int J SurgPathol, 2015, 23 (7) :531-536.
|
|
[17]van MOERKERCKE W, VERHAMME M, DOUBEL P, et al.Autoimmune pancreatitis and extrapancreatic manifestations of IgG4-related sclerosing disease[J].Acta Gastroenterol Belg, 2010, 73 (2) :239-246.
|
|
[18]VLACHOU PA, KHALILI K, JANG HJ, et al.IgG4-related sclerosing disease:autoimmune pancreatitis and extrapancreatic manifestations[J].Radiographics, 2011, 31 (5) :1379-1402.
|
|
[19]DIVATIA M, KIM SA, RO JY.IgG4-related sclerosing disease, an emerging entity:a review of a multi-system disease[J].Yonsei Med J, 2012, 53 (1) :15-34.
|
|
[20]SHIMOSEGAWA T, CHARI ST, FRULLONI L, et al.International consensus diagnostic criteria for autoimmune pancreatitis:guidelines of the International Association of Pancreatology[J].Pancreas, 2011, 40 (3) :352-358.
|
|
[21] CARRUTHERS MN, STONE JH, KHOSROSHAHI A.The latest on IgG4-RD:a rapidly emerging disease[J].Curr OpinRheumatol, 2012, 24 (1) :60-69.
|
|
[22]TABATA T, KAMISAWA T, HARA S, et al.Differentiating immunoglobulin G4-related sclerosing cholangitis from hilar cholangiocarcinoma[J].Gut Liver, 2013, 7 (2) :234-238.
|
|
[23] BOONSTRA K, CULVER EL, de BUY WL, et al.Serum immunoglobulin G4 and immunoglobulin G1 for distinguishing immunoglobulin G4-associated cholangitis from primary sclerosing cholangitis[J].Hepatology, 2014, 59 (5) :1954-1963.
|
|
[24]TAGHAVI SA, MAJD SK, SIANATI M, et al.Prevalence of IgG-4-associated cholangiopathy based on serum IgG-4 levels in patients with primary sclerosing cholangitis and its relationship with inflammatory bowel disease[J].Turk J Gastroenterol, 2016, 27 (6) :547-552.
|
|
[25]VOSSKUHL K, NEGM A A, FRAMKE T, et al.Measurement of IgG4in bile:a new approach for the diagnosis of IgG4-associated cholangiopathy[J].Endoscopy, 2012, 44 (1) :48-52.
|
|
[26]NAKAZAWA T, ANDO T, HAYASHI K, et al.Diagnostic procedures for IgG4-related sclerosing cholangitis[J].J Hepatobiliary Pancreat Sci, 2011, 18 (2) :127-136.
|
|
[27] OKAZAKI K, UCHIDA K, KOYABU M, et al.IgG4 cholangiopathy:current concept, diagnosis, and pathogenesis[J].J Hepatol, 2014, 61 (3) :690-695.
|
|
[28]TOMIYAMA T, UCHIDA K, MATSUSHITA M, et al.Comparison of steroid pulse therapy and conventional oral steroid therapy as initial treatment for autoimmune pancreatitis[J].J Gastroenterol, 2011, 46 (5) :696-704.
|
|
[29]MAILLETTE DBWL, DOORENSPLEET ME, KLARENBEEK PL, et al.Immunoglobulin G4+clones identified by next-generation sequencing dominate the B cell receptor repertoire in immunoglobulin G4 associated cholangitis[J].Hepatology, 2013, 57 (6) :2390-2398.
|
|
[30]BOONSTRA K, CULVER EL, de BUY WL, et al.Serum immunoglobulin G4 and immunoglobulin G1 for distinguishing immunoglobulin G4-associated cholangitis from primary sclerosing cholangitis[J].Hepatology, 2014, 59 (5) :1954-1963.
|
|
[31]ALSWAT K, AL-HARTHY N, MAZRANI W, et al.The spectrum of sclerosing cholangitis and the relevance of IgG4 elevations in routine practice[J].Am J Gastroenterol, 2012, 107 (1) :56-63.
|
|
[32]NOWATARI T, KOBAYASHI A, FUKUNAGA K, et al.Recognition of other organ involvement might assist in the differential diagnosis of IgG4-associated sclerosing cholangitis without apparent pancreatic involvement:report of two cases[J].Surg Today, 2012, 42 (11) :1111-1115.
|
|
[33]SANDANAYAKE NS, SINCLAIR J, ANDREOLA F, et al.A combination of serum leucine-rich alpha-2-glycoprotein 1, CA19-9 and interleukin-6 differentiate biliary tract cancer from benign biliary strictures[J].Br J Cancer, 2011, 105 (9) :1370-1378.
|
|
[34]FERRY JA, KLEPEIS V, SOHANI AR, et al.IgG4-related orbital disease and its mimics in a western population[J].Am J Surg Pathol, 2015, 39 (12) :1688-1700.
|
|
[35]WALLACE ZS, DESHPANDE V, MATTOO H, et al.IgG4-Related disease:clinical and laboratory features in one hundred twenty-five patients[J].Arthritis Rheumatol, 2015, 67 (9) :2466-2475.
|
|
[36]EBBO M, DANIEL L, PAVIC M, et al.IgG4-related systemic disease:features and treatment response in a French cohort:results of a multicenter registry[J].Medicine (Baltimore) , 2012, 91 (1) :49-56.
|
|
[37]GRADOS A, EBBO M, JEAN E, et al.IgG4-related disease treatment in 2014:update and literature review[J].Rev Med Interne, 2015, 36 (6) :395-404.
|
|
[38]EBBO M, PATIENT M, GRADOS A, et al.Ophthalmic manifestations in IgG4-related disease:Clinical presentation and response to treatment in a French case-series[J].Medicine (Baltimore) , 2017, 96 (10) :e6205.
|
|
[39]BAE JH, KIM SH, AHN SB, et al.A case of idiopathic sclerosing mesenteritis with retroperitoneal fibrosis[J].Korean J Gastroenterol, 2011, 58 (4) :221-225.
|
|
[40]CARRUTHERS MN, TOPAZIAN MD, KHOSROSHAHI A, et al.Rituximab for IgG4-related disease:a prospective, open-label trial[J].Ann Rheum Dis, 2015, 74 (6) :1171-1177.
|
|
[41]GU WJ, ZHANG Q, ZHU J, et al.Rituximab was used to treat recurrent IgG4-related hypophysitis with ophthalmopathy as the initial presentation:a case report and literature review[J].Medicine (Baltimore) , 2017, 96 (24) :e6934.
|
DownLoad: